New hope to stop strokes in young sickle cell patients
NCT ID NCT04808778
Summary
This study aims to prevent strokes in young adults with sickle cell anemia in Nigeria. Researchers will monitor 250 participants aged 16-25 for brain injuries and test whether a medication called hydroxyurea can safely reduce stroke risk. The goal is to develop better prevention strategies for this high-risk population where regular blood transfusions aren't always available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aminu Kano Teaching Hospital
Kano, Nigeria
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-9000, United States
Conditions
Explore the condition pages connected to this study.